-
The FDA has approved cyclosporine ophthalmic emulsion for the treatment of dry eyes due to keratoconjuctivitis sicca (KCS) and associated reduced tear production. Cyclosporine is an immunomodulating agent that increases tear production in patients with KCS.
-
Pravastatin given for 3 years reduced the risk of coronary disease in elderly individuals. The PROSPER study therefore extends to elderly individuals the treatment strategy currently used in middle aged people.
-
What is your practice when it comes to routinely screening teen-age girls for chlamydia? If you arent performing such testing, you are missing a prime opportunity to reduce the most commonly reported sexually transmitted disease (STD) in the United States.
-
-
Mounting federal deficits coupled with an administration that favors abstinence promotion over contraception means that funding for the Title X family planning program is likely to remain stagnant in the coming years. President Bush sought no additional funding for the program during his first two years in office, and funding increases during the late 1990s did little more than keep pace with inflation.
-
Whats the current consensus when it comes to chlamydia screening for adolescents? Take a look at national public health guidelines to help direct you in your practice.
-
The Food and Drug Administration (FDA) is proposing a labeling change for over-the-counter vaginal contraceptives containing N-9. The new labeling, when approved, will help users understand that the use of such products can increase vaginal irritation, which actually may heighten the possibility of acquiring the AIDS virus and other STDs from infected partners.
-
-
FDA Approves Claritin For OTC Use For Seasonal Rhinitis; Simpler Atrial Fibrillation Management; Oral Anticoagulation Vs Aspirin in AF; Immunization Does Not Cause Autism; Statins May Lower CRP Levels; Simvastatin Reduced CRP Plasma Levels; FDA Actions
-